Duavive (2020-05-20)
- Starting date:
- May 20, 2020
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type II
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-73183
Last updated: 2020-05-26
Summary
-
Product:
Duavive Tablet
Reason
The affected lots may not meet the specification for dissolution of bazedoxifene during the product shelf-life.
Depth of distribution
Wholesalers, Retailers
Affected products
Duavive Tablet
DIN, NPN, DIN-HIM
DIN 02432854
Dosage form
Tablet (Immediate And Extended Release)
Strength
Bazedoxifene 20 mg
Conjugated Estrogens 0.45 mg
Lot or serial number
AH6679, X51932, DC8998, AN0290
Companies
- Recalling Firm
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA
- Marketing Authorization Holder
-
Pfizer Canada Inc.
17300 Trans-Canada Hwy.
Kirkland
H9J 2M5
Ontario
CANADA